AnivanceAI has been selected as one of the “Top 30 finalists” for the VivaTech Innovation of the Year 2025

This recognition places us among the world’s most promising deep tech startups — and affirms our commitment to transforming drug development through organ-on-chip innovation and predictive AI.

Thank you to VivaTech and TechCrunch for this opportunity, and to our partners and team who continue to drive our mission forward.

Let’s keep building a faster, more human-relevant future — together.